Eric H. Bernicker, MD

  • Houston Methodist thoracic medical oncologist
  • Director of medical thoracic oncology, Houston Methodist Cancer Center
  • Associate Professor of Clinical Medicine, Weill Cornell Medical College

Eric H. Bernicker, MD

Areas of Expertise

  • Cancer clinical trials
  • Eye cancers
  • Head/neck cancers
  • Immunotherapies and other targeted therapeutics
  • Lung cancer (non-small cell and small cell)
  • Mesothelioma

Credentials

BOARD CERTIFICATION
Medical Oncology | American Board of Internal Medicine
MEDICAL SCHOOL
Baylor College of Medicine - Houston, TX | 1990
RESIDENCY
Baylor College of Medicine - Houston, TX | 1994
FELLOWSHIP
Hematology | Baylor College of Medicine - Houston, TX | 1995
Medical Oncology | MD Anderson Cancer Center - Houston, TX | 1996

Publications

Outcomes and prognostic contributors in patients with KRAS mutated non-small cell pulmonary adenocarcinomas: A single institution experience
Burns, EA, Ensor, JE, Hsu, J, Thomas, JS, Olsen, RJ & Bernicker, EH 2021, , Journal of Thoracic Disease, vol. 13, no. 8, pp. 4785-4796. https://doi.org/10.21037/jtd-21-432

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
Grivas, P, Khaki, AR, Wise-Draper, TM, French, B, Hennessy, C, Hsu, CY, Shyr, Y, Li, X, Choueiri, TK, Painter, CA, Peters, S, Rini, BI, Thompson, MA, Mishra, S, Rivera, DR, Acoba, JD, Abidi, MZ, Bakouny, Z, Bashir, B, Bekaii-Saab, T, Berg, S, Bernicker, EH, Bilen, MA, Bindal, P, Bishnoi, R, Bouganim, N, Bowles, DW, Cabal, A, Caimi, PF, Chism, DD, Crowell, J, Curran, C, Desai, A, Dixon, B, Doroshow, DB, Durbin, EB, Elkrief, A, Farmakiotis, D, Fazio, A, Fecher, LA, Flora, DB, Friese, CR, Fu, J, Gadgeel, SM, Galsky, MD, Gill, DM, Glover, MJ, Goyal, S, Grover, P, Gulati, S, Gupta, S, Halabi, S, Halfdanarson, TR, Halmos, B, Hausrath, DJ, Hawley, JE, Hsu, E, Huynh-Le, M, Hwang, C, Jani, C, Jayaraj, A, Johnson, DB, Kasi, A, Khan, H, Koshkin, VS, Kuderer, NM, Kwon, DH, Lammers, PE, Li, A, Loaiza-Bonilla, A, Low, CA, Lustberg, MB, Lyman, GH, McKay, RR, McNair, C, Menon, H, Mesa, RA, Mico, V, Mundt, D, Nagaraj, G, Nakasone, ES, Nakayama, J, Nizam, A, Nock, NL, Park, C, Patel, JM, Patel, KG, Peddi, P, Pennell, NA, Piper-Vallillo, AJ, Puc, M, Ravindranathan, D, Reeves, ME, Reuben, DY, Rosenstein, L, Rosovsky, RP, Rubinstein, SM, Salazar, M, Schmidt, AL, Schwartz, GK, Shah, MR, Shah, SA, Shah, C, Shaya, JA, Singh, SRK, Smits, M, Stockerl-Goldstein, KE, Stover, DG, Streckfuss, M, Subbiah, S, Tachiki, L, Tadesse, E, Thakkar, A, Tucker, MD, Verma, AK, Vinh, DC, Weiss, M, Wu, JT, Wulff-Burchfield, E, Xie, Z, Yu, PP, Zhang, T, Zhou, AY, Zhu, H, Zubiri, L, Shah, DP, Warner, JL & Lopes, GL 2021, , Annals of Oncology, vol. 32, no. 6, pp. 787-800. https://doi.org/10.1016/j.annonc.2021.02.024

Concomitant mutation status of ALK-rearranged non-small cell lung cancers and its prognostic impact on patients treated with crizotinib
Li, J, Zhang, B, Zhang, Y, Xu, F, Zhang, Z, Shao, L, Yan, C, Ulivi, P, Denis, MG, Christopoulos, P, de Montpréville, VT, Bernicker, EH, van der Wekken, AJ, Wang, C & Yue, D 2021, , Translational Lung Cancer Research, vol. 10, no. 3, pp. 1525-1535. https://doi.org/10.21037/tlcr-21-160

Adherence to National Comprehensive Cancer Network ALK Testing Guidelines for Patients with Advanced Non-Small Cell Lung Cancer in U.S. Community Medical Centers
Bernicker, EH, Xiao, Y, Abraham, A, Yang, B, Croix, DA, Redpath, S, Engstrom-Melnyk, J, Shah, R, Madala, J & Allen, TC 2021, , Oncologist, vol. 26, no. 6, pp. e1050-e1057. https://doi.org/10.1002/onco.13779


Understanding the associations between smoking-related risk perception, interest in quitting smoking, and interest in lung cancer screening among homeless adult smokers
Agrawal, P, Taing, M, Chen, TA, Reuven, SM, Businelle, MS, Kendzor, DE, Bernicker, EH & Reitzel, LR 2020, , International journal of environmental research and public health, vol. 17, no. 23, 8817, pp. 1-11. https://doi.org/10.3390/ijerph17238817

Clinical Utility of Reflex Ordered Testing for Molecular Biomarkers in Lung Adenocarcinoma
Anand, K, Phung, TL, Bernicker, EH, Cagle, PT, Olsen, RJ & Thomas, JS 2020, , Clinical Lung Cancer, vol. 21, no. 5, pp. 437-442. https://doi.org/10.1016/j.cllc.2020.05.007

Eye plaque brachytherapy versus enucleation for ocular melanoma: an analysis from the National Cancer Database
Messer, JA, Zuhour, RJ, Haque, W, Lewis, GD, Schefler, AC, Wong, A, Bernicker, EH, Chevez-Barrios, P, Michelle Quan, E, Farach, A, Butler, EB, Hatch, SS & Teh, BS 2020, , Journal of Contemporary Brachytherapy, vol. 12, no. 4, pp. 303-310. https://doi.org/10.5114/jcb.2020.98108

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
COVID-19 and Cancer Consortium 2020, , The Lancet, vol. 395, no. 10241, pp. 1907-1918. https://doi.org/10.1016/S0140-6736(20)31187-9

Hyperprogressive NSCLC With Two Immune-Checkpoint Inhibitors
Kasparian, S, Gentille, C, Burns, E & Bernicker, EH 2020, , JTO Clinical and Research Reports, vol. 1, no. 2, 100017. https://doi.org/10.1016/j.jtocrr.2020.100017

Cancer cachexia: A multifactoral disease that needs a multimodal approach
Stubbins, R, Bernicker, EH & Quigley, EM 2020, , Current opinion in gastroenterology, vol. 36, no. 2, pp. 141-146. https://doi.org/10.1097/MOG.0000000000000603

Panuveitis in patient on ipilimumab/nivolumab combination for small-cell lung cancer treated with an intravitreal dexamethasone implant
L Hefler, J, M Bailey, L, El Rahi, C, C Schefler, A & Bernicker, EH 2021, , Journal of Oncology Pharmacy Practice, vol. 27, no. 5, pp. 1261-1264. https://doi.org/10.1177/1078155220969792

Osimertinib-Induced Cardiotoxicity: A Retrospective Review of the FDA Adverse Events Reporting System (FAERS)
Anand, K, Ensor, J, Trachtenberg, B & Bernicker, EH 2019, , JACC: CardioOncology, vol. 1, no. 2, pp. 172-178. https://doi.org/10.1016/j.jaccao.2019.10.006

Immune Checkpoint Inhibitor-Related Adverse Cardiovascular Events in Patients With Lung Cancer
Chitturi, KR, Xu, J, Araujo-Gutierrez, R, Bhimaraj, A, Guha, A, Hussain, I, Kassi, M, Bernicker, EH & Trachtenberg, BH 2019, , JACC: CardioOncology, vol. 1, no. 2, pp. 182-192. https://doi.org/10.1016/j.jaccao.2019.11.013

A matter of comprehensive informed consent: Short-term mortality rates with definitive treatment options in elderly stage i NSCLC
Dalwadi, SM, Savjani, RR, Bernicker, EH, Butler, EB, Teh, BS & Farach, AM 2019, , American Journal of Clinical Oncology: Cancer Clinical Trials, vol. 42, no. 11, pp. 851-855. https://doi.org/10.1097/COC.0000000000000606

Socioeconomic Factors Associated with Lack of Treatment in Early Stage Non-Small Cell Lung Cancer
Dalwadi, SM, Zhang, J, Bernicker, EH, Butler, EB, Teh, BS & Farach, AM 2019, , Cancer Investigation, vol. 37, no. 9, pp. 506-511. https://doi.org/10.1080/07357907.2019.1666136


Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma
Schefler, AC, Koca, E, Bernicker, EH & Correa, ZM 2019, , Graefes Archive for Clinical and Experimental Ophthalmology, vol. 257, no. 7, pp. 1541-1545. https://doi.org/10.1007/s00417-019-04335-w

Disparities in the Treatment and Outcome of Stage I Non–Small-Cell Lung Cancer in the 21st Century
Dalwadi, SM, Lewis, GD, Bernicker, EH, Butler, EB, Teh, BS & Farach, AM 2019, , Clinical Lung Cancer, vol. 20, no. 3, pp. 194-200. https://doi.org/10.1016/j.cllc.2018.11.004

Update on emerging biomarkers in lung cancer
Bernicker, EH, Allen, TC & Cagle, PT 2019, , Journal of Thoracic Disease, vol. 11, pp. S81-S88. https://doi.org/10.21037/jtd.2019.01.46

Languages

  • English